My understanding of the current regulations is that they can strongly suggest to manufacturers that they take their product off the market once serious adverse reactions are reported, yet they do not have the regulatory power at this point in time to mandate it.
I think that would be a step in the right direction for the government agency that oversees the safety of the Canadian public and the use of drugs.